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Available online 24 December 2015To determine the incidence of lower-extremity lymphedema after surgical therapy including lymphadenectomy
in endometrial cancer patients using standardized leg measurements. Also, to determine additional risk factors
for the development of lymphedema and to study the effect of lymphedema on one's quality of life. In this pro-
spective cohort study, patients with the diagnosis of endometrial cancerwhowere to undergo deﬁnitive surgical
management were evaluated pre-operatively and followed post-operatively over the course of two years. Stan-
dardized leg measurements were performed by the same individuals at six time-points. Subjects also completed
a standardized quality-of-life survey at each time-point. The incidence of lymphedema in 39 womenwith endo-
metrial cancer using a standardized legmeasurement protocol was 12.8%with lymphedema deﬁned as a 20% in-
crease in post-operative leg measurements. There was no signiﬁcant association between the development of
lymphedema and the number of pelvic or para-aortic lymph nodes removed, medical comorbidities, or surgical
approach (p N 0.05). Of theﬁve patientswhomet criteria for lymphedema, only one hadworsening quality-of-life
concerns post-operatively on the FACT-En, version 4, survey. This is theﬁrst prospective study using standardized
leg measurements to calculate the incidence of post-operative lymphedema in endometrial cancer. Medical co-
morbidities, surgical approach, number of lymph nodes removed, and location of lymph nodes removed did
not appear to affect the development of lymphedema in this cohort. A prospective, multicenter trial is needed
to conﬁrm these ﬁndings and to further assess the impact of lymphedema on one's quality of life.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Acquired lower-extremity lymphedema occurs after external inter-
ruption to the lymphatic system in some gynecologic cancer patients.
Endolymphatic pressure increases in the lymphatic vessels and histo-
logical changes of the vessels ensue which causes protein-rich ﬂuid to
accumulate in the interstitial spaces of the lower-extremity (Mihara
et al., 2012). The course of acquired or secondary lymphedema is
often chronic and can lead to a worse quality of life in this subset of
the gynecologic cancer patient population (Ridner, 2013). The incidence
of lymphedema in gynecologic malignancies has been reported as 20%
in one systematic review and reported as a range of 6–37% in a retro-
spective chart review (Cormier et al., 2010; Hareyama et al., 2012).
Speciﬁcally, patients undergoing lymphadenectomy secondary to endo-
metrial cancer develop lower-extremity edema in 1.2 to 37.8% of cases. This is an open access article under(Tada et al., 2009; Abu-Rustum et al., 2006; Todo et al., 2010; Pereira
de Godoy et al., 2002).
The risk of lymphedema has previously been correlated with the
number of lymph nodes removed. Abu-Rustum et al. (2006) demon-
strated that a higher number of lymph nodes removed increase the
chance of developing lower-extremity edema. Multiple studies have
shown that preservation of the circumﬂex iliac lymph nodes decreases
the incidence of lower-extremity lymphedema (Hareyama et al.,
2012; Todo et al., 2010). A retrospective chart review of 286 patients
showed that removal of greater than 31 lymph nodes, radiation therapy,
and removal of circumﬂex iliac nodes distal to the external iliac nodes
(CINDEIN) increased the risk of lower-extremity lymphedema (Todo
et al., 2010).
It is critical to delineate the incidence and risk factors leading to
lower-extremity lymphedema as this condition can negatively impact
a patient's quality of life physically, mentally, and sexually (Pereira de
Godoy et al., 2002; Carter et al., 2013; Beesley et al., 2007). From a re-
cent comprehensive review of the literature, lymphedema associatedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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esteem issues, increased anxiety or fear about their disease, and ad-
versely affect their sexual health (Carter et al., 2013).
The objective of this prospective studywas to calculate the incidence
of lower-extremity lymphedema after lymphadenectomy in patients
with endometrial cancer using standardized leg measurements. This
study also examined variables thought to increase the likelihood of
lymphedema including medical comorbidities, surgical approach, and
number of pelvic and para-aortic lymphnodes removed.We also looked
at quality-of-life issues relating to lymphedema.
2. Materials and methods
This prospective cohort study was approved by the Medical College
of Wisconsin/Froedtert Hospital Institutional Review Board. To be in-
cluded, a woman had to have a diagnosis of endometrial cancer and
had not yet undergone deﬁnitive surgical management. We included
subjects regardless of age, race, or body mass index. Women were ex-
cluded from the study if they had pre-existing lower extremity edema
or were in poor health and could not attend follow-up appointments.
Amember of the research teamobtained informed consent from the
subject. Pre-operatively, information on each subject was collected in-
cluding age at enrollment, medical comorbidities, and body mass
index. Also during the pre-operative period, the subject ﬁlled out a
quality-of-life survey called the Functional Assessment of Cancer Thera-
py in Endometrial Cancer Version 4 (FACT-En, version 4). The survey
asked about pain in the pelvic area, weight concerns, leg appearance,
leg function, and generalized pain of the leg (Fig. 1). The subject then
had baseline bilateral leg measurements, which consisted of measuring
the width of the leg three inches (7.62 cm) above the lateral malleolus,
ﬁve inches (12.7 cm) below the patella, and ﬁve inches (12.7 cm) above
the patella (Fig. 2).
The subject underwent an initial staging surgery performed by a gy-
necologic oncologist at Froedtert Hospital that included a pelvic and/or
para-aortic lymph node dissection, which involved surgical techniques
including electrocautery, clips, and sharp dissection.We obtained oper-
ative data on the subjects,which included pathology of the tumor, stage,
grade, total number of pelvic and para-aortic lymph nodes and surgical
approach (laparotomy versus laparoscopy).
The subject was followed for two years post-operatively. The same
two nurses took bilateral leg measurements in the exact fashion as per-
formed pre-operatively at three months, six to nine months, one year,
and two year time points. At these visits, the subjects were weighed
and completed the same quality-of-life survey.
For analysis of the data, subjects who had any type of leg measure-
ments increased by greater than 20% using the standardized leg mea-
surement system by one or two years post-operatively were deﬁned
as having “lymphedema.” A chi-square test was performed to look for
a signiﬁcant association between medical comorbidities (congestiveFig. 1. Questions from the FACT-En, version 4 quality-of-life survey.heart failure, diabetes, coronary artery disease, varicose veins, peripher-
al vascular disease, hypertension) and lymphedema in endometrial can-
cer. It was also used to determine if a signiﬁcant association existed
between surgical approach and development of lymphedema. A two
sample t-test was performed to determine the signiﬁcance of total pel-
vic and para-aortic lymph nodes removed in the development of
lymphedema. We then qualitatively analyzed the completed quality-
of-life surveys.
3. Results
FromMarch2005 to January 2008, 50womenwith endometrial can-
cer were enrolled in the study. Data collection began inMarch 2005 and
continued until December 2009.
Eleven subjects were removed from the study due to self-
withdrawal (two subjects), death (three subjects) and incomplete
data in greater than 50% of variables (six subjects).
The remaining 39 women were evaluated at the speciﬁed time
points post-operatively. The average follow-up visit rate of the 39 sub-
jects at any given time point was 90%.
The incidence of lymphedema in subjects with endometrial cancer
as deﬁned by greater than 20% increase in leg measurements post-
operatively was 12.8% (5/39 subjects). Of the ﬁve subjects who devel-
oped lymphedema, three subjects developed lymphedema at one year
post-operatively, and two subjects developed lymphedema two years
post-operatively. Three subjects developed lymphedema in both legs
while two subjects developed lymphedema in one leg. None of the sub-
jects who developed lymphedema had immediate post-operative com-
plications or had recurrence of disease. The ﬁve subjects who developed
lymphedema had a total of 12 to 41 pelvic and para-aortic lymph nodes
removed and had Stage 1A to Stage 1B endometrial cancer. Themajority
of subjects in the study also had Stage IA to IB disease. In patients with
lymphedema, the average number of pelvic lymph nodes removed
was 14.60 compared to an average number of 15.47 pelvic lymph
nodes in those subjects who did not develop lymphedema. In patients
with lymphedema, the average number of para-aortic lymph nodes re-
moved was 7.60 compared to an average number of 5.79 para-aortic
lymph nodes in those subjects who did not develop lymphedema.
Of the 39 subjects, 44% had signiﬁcant medical comorbidities previ-
ously deﬁned. Twenty-two of 39 subjects (56%) underwent laparotomy
and 17 subjects (44%) underwent laparoscopy for the surgical staging
procedure. When looking at the covariates in Table 1 of medical comor-
bidities, surgical approach, and the total number and type of lymph
nodes removed, there was no signiﬁcant association between these co-
variates and the incidence of lymphedema (p-value N0.05).
When qualitatively looking at worsening quality-of-life issues, the
minority of subjects in the study (8/39) had pelvic pain and change in
weight, leg pain, leg appearance, or leg function. Table 2 shows that
only one of the ﬁve patients who developed lymphedema answered
“quite a bit” to “very much” to the quality-of-life questions pertaining
to lower extremities (Fig. 2) at one year to two years postoperatively.
4. Discussion
We found the incidence of lymphedema in this prospective study of
women with endometrial cancer to be 12.8% (5 of 39 patients) over a
two-year post-operative interval. We also found that medical history,
surgical approach, and the location or number of lymph nodes removed
did not inﬂuence the development of lymphedema (p N 0.05).
To our knowledge, this is the ﬁrst prospective study looking at the
incidence of lymphedema in endometrial cancer using a standardized
reporting system of lower leg edema postoperatively. An OVIDMedline
search was conducted searching the literature from 1950 to the present
which contained the terms “lymphedema,” “postoperative,” and “endo-
metrial neoplasms.”
Fig. 2. Depiction of standardized leg measurement system.
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reported range in the literature for lymphedema developing after surgi-
cal therapy for endometrial cancer (Tada et al., 2009; Abu-Rustum et al.,
2006; Todo et al., 2010; Ghezzi et al., 2010). Lymphedema deﬁned as
20% or greater increase in legmeasurementswas utilized as an arbitrary
deﬁnition due to the paucity of exact description of lymphedema in the
literature. Prior studies have often utilized subjective instead of objec-
tive criteria to deﬁne lymphedema and for that reason this deﬁnition
has not been established. The cutoff of 20% acted to decrease inﬂation
of the incidence of lymphedema in this study. There have been prior ret-
rospective studies that have documented the incidence of lymphedema
in endometrial cancer, such as the 12-year retrospective chart review
performed at Memorial Sloan-Kettering Cancer Center. This retrospec-
tive study of 1289 patients found the incidence of lymphedema to be
1.2% after median follow-up period of three years. They focused on
symptomatic lymphedema only and did not perform serial measure-
ments as in our study (Abu-Rustum et al., 2006). Todo et al. (2010) re-
ported a higher rate of 37.8% of lower-extremity lymphedema based
on a retrospective chart review of 286 patients. From our review of
the literature, it is evident that the main strength of our study is its pro-
spective nature, the standardized fashion in which the leg measure-
ments were performed, and that the leg measurements were all
performed by the same two individuals. This consistency lends strength
to the 12.8% incidence of lymphedema found in this study.
In this study, surgical approach of laparotomy compared to laparos-
copy did not have a signiﬁcant inﬂuence on the incidence of lymphede-
ma. Our conclusion that the type of surgical approach did not
signiﬁcantly affect the development of lymphedema in endometrial
cancer is supported by Ghezzi et al. (2010), who retrospectively foundTable 1
Effect of variables on the development of lymphedema.a
p-Value
Medical comorbidities 0.64
Surgical approach 0.64
Total pelvic lymph nodes removed 0.72
Total para-aortic lymph nodes removed 0.70
a Data are p-values with a signiﬁcant p-value b0.05.no difference between the rates of lymphedemawith an open approach
compared to a laparoscopic approach.
In terms of past medical history, the majority of women had no sig-
niﬁcant comorbidities in this study. It is thought that ﬁve to six percent
of women will present with chronic lower extremity edema preopera-
tively related to various comorbidities (Abu-Rustum et al., 2006). Hy-
pertension was the most common comorbidity of the subjects in this
study.
The majority of subjects' quality of life at the end of the two-year
follow-up period, in terms of pelvic pain and change in weight, leg
pain, leg appearance, or leg function,was not affected through a qualita-
tive analysis. Only one subject with lymphedema reported worsening
problems. As one would predict more of the patients who developed
lymphedema to have quality-of-life concerns with the affected leg(s),
future studies with a larger sample size of women with lymphedema
and a more comprehensive list of quality-of-life issues are needed to
further investigate the impact of lymphedema on quality of life.
Themain limitation of our studywas its small sample size. This study
represents a single institution's experience. The subjects who were en-
rolled into the study were recruited over a period of greater than two
years. Our strengths, however, include an excellent average rate of
follow-up at any given time point over two years after enrollment
which lends to the validity of our conclusions.
Our study acts as a pilot study and implicates the need for a larger,
multi-center prospective study to delineate the impact of this survivor-
ship issue, lymphedema, on the endometrial cancer patient population
and the gynecologic cancer patient population as a whole. This study
should include a standardized approach to leg measurement to de-
crease the amount of discrepancy of the incidence of lymphedema re-
ported in the literature. It would also be useful to address moreTable 2
Responses to FACT-En, version 4 quality-of-life survey.a
Time point Number of subjects with one or more
responses to quality-of-life survey ≥3
Number of these
subjects with
lymphedema
1-year postoperative 8 (21%) 1 (3%)
2-year postoperative 8 (21%) 1 (3%)
a On the FACT-En, version 4 survey, a response of “3” to a question equates to “quite a
bit” and a response of “4” to a question equates to “very much.” Data are n or n (%).
28 E.E. Hopp et al. / Gynecologic Oncology Reports 15 (2016) 25–28quality-of-life questions important to the cancer population. Our study
shows the importance of pre-operative counseling on the risk of lymph-
edemaprior to surgery for endometrial cancer as an incidence of lymph-
edema of 12.8% should not be overlooked.
In conclusion, our study demonstrates that in a single institution by
using a standardized, prospective approach, the incidence of lymphede-
ma in womenwith endometrial cancer who have undergone a compre-
hensive stagingprocedurewith lymphnodedissection is 12.8% andmay
evolve over the course of up to two years post surgery. The majority of
women did not experience a signiﬁcant negative impact on their quality
of life with regards to change in weight, leg discomfort, or pain. The de-
velopment of lymphedema in our subjects appeared to be a process not
inﬂuenced by the number or location of lymph nodes removed, surgical
approach, or medical comorbidities.
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